Stocks · Health care · Pharmaceutical Preparations

Q32 Bio Inc.

FIXX Clue Score74
United States Fiscal year ends December CIK 0001661998 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Orbimed Advisors LLC
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Orbimed Advisors LLC
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
Diyong Xu
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Diyong Xu
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 499,021
History held since 29 Mar 2018